HistoSonics and Cambridge University Introduce Europe’s First Edison™ Histotripsy System
June 10, 2025
Breakthrough Non-Invasive Therapy Installed with Support from Li Ka Shing Foundation to Advance Research and Patient Care
Breakthrough Non-Invasive Therapy Installed with Support from Li Ka Shing Foundation to Advance Research and Patient Care
A team of scientists and biomedical engineers developing pioneering technology designed to treat threatened miscarriage has secured 1 million GBP in Invention for Innovation (i4i) funding from the National Institute for Health and Care Research (NIHR) for its first clinical trial.
Mediplus has announced the release of new sizes of the POPY (Pelvic Organ Prolapse pessary) product range. The company is introducing five additional sizes to complement its existing products, offering a more precise fit and enhanced treatment options for women suffering from pelvic organ prolapse.
Medtronic has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Visualase V2 MRI-Guided Laser Ablation System. This milestone brings important capital system enhancements to the Visualase platform, which provides a minimally invasive surgical option for patients with focal epilepsy, brain tumors, and radiation necrosis, which impacts over 1 million people total worldwide.
Insulet (Nasdaq: PODD)+
today announced a new integration for its Omnipod 5 platform, building on its partnership with Dexcom (Nasdaq: DXCM)
TEL AVIV, Israel, June 9, 2025 /PRNewswire/ — Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical implantations were performed on Friday, May 16, 2025, at New York-Presbyterian/Columbia University Irving Medical Center by Dr. Koji Takeda, Surgical Director for Adult Heart Transplant at New York-Presbyterian/Columbia.
IceCure has 20+ patents in the U.S. and the Company anticipates further market traction upon FDA’s marketing authorization decision in early-stage breast cancer
HOUSTON, June 9, 2025 /PRNewswire/ — TYBR Health, a medical device and regenerative medicine company, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the B3 GEL™ System. B3 GEL™ is a bioresorbable, flowable gel barrier designed to protect healing tissue planes and preserve mobility following surgeries involving tendons, ligaments, and skeletal muscle.
Olympus announced today that it has fully launched its AI-driven emphysema screening program, SeleCT Screening.
ST PAUL, Minn., June 9, 2025 /PRNewswire/ — Solventum, a global MedTech leader at the forefront of infection prevention innovation, today announced the launch of its Attest™ Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack. The ready-to-use test integrates two previously FDA-cleared indicators – a biological indicator (BI) for confirming microbial neutralization and a chemical indicator (CI) for verifying proper sterilizer function – into a single-use test pack with a transparent container.